-
Another fluoroquinolone has been added to the list of antibacterial agents for respiratory tract infections. Gemifloxacin is a broad-spectrum agent that is highly active against the most common respiratory pathogens, including penicillin and macrolide resistant Streptococcus pneumoniae.
-
-
Pneumococcal Vaccine Ineffective at CAP Prevention; Flu Vaccine Limits
Hospitalization; Verapamil Not Up To Competition; International
Companies Unite Against SARS; New FDA Comissioner Brings Controversy;
Janssen: Dear Doctor Letter for Risperidone
-
The ECG in the Figure was obtained from a 41-year-old woman with chest pain of suspected cardiac etiology. The tracing shows complete RBBB (right bundle branch block). How many additional ECG findings of potential concern can you identify that may be relevant in view of this patients clinical history?
-
Direct-to-consumer marketing of helical computed tomography (CT) screening for older adult smokers is not advisable.
-
Some patients seem to develop chronic irritable bowel syndrome following an episode of gastroenteritis, possibly based on excessive mucosal serotonin release.
-
The addition of eplerenone to optimal medical therapy reduces morbidity and mortality among patients with acute myocardial infarction complicated by left ventricular dysfunction and heart failure.
-
-
The FDA has approved the first once-daily protease inhibitor (PI) for the treatment of HIV-1 infections. Atazanavir (Bristol-Myers Squibb) is the newest PI to enter this relatively crowded class. It is marketed under the trade name Reyataz.
-
Women who survive breast cancer may be at a lower risk of developing coronary artery disease compared with women without a history of breast cancer.